Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disseminated toxoplasmosis after hematopoietic stem cell transplantation showing unusual magnetic resonance images.
Tateno T, Onozawa M, Hashiguchi J, Ishio T, Yuzawa S, Matsuoka S, Kosugi-Kanaya M, Okada K, Shiratori S, Goto H, Kimura T, Sugita J, Nakagawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Kondo T, Tanaka S, Hashino S, Teshima T. Tateno T, et al. Among authors: sugita j. Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12720. Epub 2017 Jun 20. Transpl Infect Dis. 2017. PMID: 28474756
Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Toubai T, Tanaka J, Nishihira J, Ohkawara T, Hirate D, Kondo N, Tone S, Shono Y, Ibata M, Sugita J, Kato N, Miura Y, Iwao N, Ota S, Imamura M. Toubai T, et al. Among authors: sugita j. Transpl Immunol. 2006 Aug;16(2):117-24. doi: 10.1016/j.trim.2006.05.001. Epub 2006 Jun 19. Transpl Immunol. 2006. PMID: 16860715
Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group.
Sugita J, Tanaka J, Kurosawa M, Fukuhara T, Hashino S, Torimoto E, Koizumi K, Masauji N, Nishimura S, Koda K, Imamura M, Kasai M; Hokkaido Hematology Study Group. Sugita J, et al. Eur J Haematol. 2008 Feb;80(2):160-3. doi: 10.1111/j.1600-0609.2007.00982.x. Epub 2007 Nov 17. Eur J Haematol. 2008. PMID: 18028432
Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma.
Toubai T, Hirate D, Shono Y, Ota S, Ibata M, Mashiko S, Sugita J, Shigematsu A, Miura Y, Kato N, Umehara S, Kahata K, Tsutsumi Y, Iwao N, Toyoshima N, Tanaka J, Asaka M, Imamura M. Toubai T, et al. Among authors: sugita j. Int J Lab Hematol. 2008 Feb;30(1):75-81. doi: 10.1111/j.1751-553X.2007.00903.x. Int J Lab Hematol. 2008. PMID: 18190473
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Shigematsu A, et al. Among authors: sugita j. Biol Blood Marrow Transplant. 2008 May;14(5):568-75. doi: 10.1016/j.bbmt.2008.02.018. Biol Blood Marrow Transplant. 2008. PMID: 18410899 Free article.
A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
Shiratori S, Yasumoto A, Tanaka J, Shigematsu A, Yamamoto S, Nishio M, Hashino S, Morita R, Takahata M, Onozawa M, Kahata K, Kondo T, Ota S, Wakasa K, Sugita J, Koike T, Asaka M, Kasai M, Imamura M. Shiratori S, et al. Among authors: sugita j. Biol Blood Marrow Transplant. 2008 Jul;14(7):817-23. doi: 10.1016/j.bbmt.2008.04.014. Biol Blood Marrow Transplant. 2008. PMID: 18541202 Free article.
197 results